跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 331,001 条关于
“immunoglobulin A (IgA) nephropathy”
全部
331,001
临床试验
280,036
药物
6,212
机构
4,022
资讯
40,731
去年
FDA Grants Breakthrough Therapy Designation to OMS721 for IgA Nephropathy
去年
Atrasentan Significantly Reduces Proteinuria in IgA Nephropathy Patients: Phase III ALIGN Trial
去年
Otsuka's Sibeprenlimab Shows Positive Phase 3 Interim Results for IgA Nephropathy
去年
Otsuka's Sibeprenlimab Achieves 51% Reduction in Proteinuria for IgA Nephropathy, Intensifying Competition with Vera Therapeutics
2年前
Novartis's Atrasentan Shows Promise with Projected $229M Revenue by 2033 for Kidney Diseases
去年
Hansa Biopharma Appoints Renée Aguiar-Lucander as New CEO, Marking New Growth Phase
2年前
FDA Approves Fabhalta (Iptacopan) as First Oral Monotherapy for PNH
3年前
Targeting the Endothelin A Receptor in IgA Nephropathy: A New Therapeutic Approach
去年
Otsuka Submits BLA for Sibeprenlimab: A Novel Targeted Therapy for IgA Nephropathy
4年前
Phase II Study Shows Atacicept's Potential in Treating IgA Nephropathy
第 1 页，共 4074 页
上一页
下一页
